Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder associated with
progressive loss of cognitive function. 2-[18 F] fluoro-2-deoxy-d-glucose (FDG) positron …

Recent cerebral blood flow (CBF) and glucose consumption (CMRglc) studies of Parkinson's
disease (PD) revealed conflicting results. Using simulated data, we previously demonstrated …

Importance Converging evidence suggests that Alzheimer disease (AD) involves insulin
signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose …

Decision forests (also known as random forests) are an indispensable tool for automatic
image analysis. This practical and easy-to-follow text explores the theoretical underpinnings …

Neurodegenerative disorders, such as Alzheimer's disease, are associated with changes in
multiple neuroimaging and biological measures. These may provide complementary …

Accurate diagnosis of Alzheimer's disease (AD) and its prodromal stage mild cognitive
impairment (MCI) is of great interest to patients and clinicians. Recent studies have …

Abstract [18 F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely
used diagnostic tool that can detect and quantify pathophysiology, as assessed through …

Diagnostic accuracy in FDG-PET imaging highly depends on the operating procedures. In
this clinical study on dementia, we compared the diagnostic accuracy at a single-subject …

Involvement of the default mode network (DMN) in cognitive symptoms of Parkinson's
disease (PD) has been reported by resting‐state functional MRI (rsfMRI) studies. However …

The differential diagnosis of neurodegenerative brain diseases on clinical grounds is
difficult, especially at an early disease stage. Several studies have found specific regional …